Evogene (EVGN) Change in Acquisitions & Divestments (2013 - 2025)
Evogene (EVGN) posted Change in Acquisitions & Divestments of -$1.0 million for Q2 2025, up 56.92% sequentially from -$2.3 million in Q1 2025, and down 115.5% YoY from $6.5 million in Q2 2024.
Evogene (EVGN) Change in Acquisitions & Divestments (2013 - 2025) Analysis & Trends
Evogene has reported Change in Acquisitions & Divestments for 13 years, with the latest figure at -$1.0 million in Q2 2025.
- Quarterly Change in Acquisitions & Divestments fell 115.5% year-over-year to -$1.0 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $7.9 million (up 79.11% YoY) and the FY2024 annual result came in at $27.3 million, up 294.86% from the prior year.
- Change in Acquisitions & Divestments improved to -$1.0 million in Q2 2025 per EVGN's latest filing, from -$2.3 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $9.4 million in Q1 2022 and troughed at -$5.4 million in Q1 2024.
- A 5-year average of $2.0 million and a median of $624000.0 in 2021 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments surged 942500.0% in 2022, then tumbled 12600.0% in 2023.
- Over 5 years, Change in Acquisitions & Divestments stood at $3.4 million in 2021, then sank by 99.88% to $4000.0 in 2022, then sank by 12600.0% to -$500000.0 in 2023, then jumped by 1916.0% to $9.1 million in 2024, then slumped by 111.04% to -$1.0 million in 2025.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered -$1.0 million, -$2.3 million, and $9.1 million for Q2 2025, Q1 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Evogene | 4.38 Mn | 4.38 Mn | 204,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -1.00 Mn |
| Jun 30, 2025 | -1.00 Mn |
| Mar 31, 2025 | -2.33 Mn |
| Mar 31, 2025 | -2.33 Mn |
| Dec 31, 2024 | 9.08 Mn |
| Dec 31, 2024 | 9.08 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Jun 30, 2024 | 6.47 Mn |
| Jun 30, 2024 | 6.47 Mn |
| Mar 31, 2024 | -5.44 Mn |
| Mar 31, 2024 | -5.44 Mn |
| Dec 31, 2023 | -500,000.00 |
| Dec 31, 2023 | -500,000.00 |
| Sep 30, 2023 | 3.86 Mn |
| Sep 30, 2023 | 3.86 Mn |
| Jun 30, 2023 | 6.29 Mn |
| Jun 30, 2023 | 6.29 Mn |
| Mar 31, 2023 | 637,000.00 |
| Mar 31, 2023 | 637,000.00 |